News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,368 Results
Type
Article (49314)
Company Profile (259)
Press Release (691795)
Multimedia
Podcasts (100)
Webinars (13)
Section
Business (215458)
Career Advice (2522)
Deals (36480)
Drug Delivery (112)
Drug Development (83922)
Employer Resources (178)
FDA (16838)
Job Trends (15655)
News (362546)
Policy (34577)
Tag
Academia (2746)
Academic (1)
Accelerated approval (5)
Adcomms (21)
Allergies (94)
Alliances (53081)
ALS (100)
Alzheimer's disease (1422)
Antibody-drug conjugate (ADC) (142)
Approvals (16825)
Artificial intelligence (288)
Autoimmune disease (24)
Automation (16)
Bankruptcy (367)
Best Places to Work (12034)
BIOSECURE Act (21)
Biosimilars (110)
Biotechnology (182)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (301)
Cancer (2391)
Cardiovascular disease (189)
Career advice (2118)
Career pathing (33)
CAR-T (159)
Cell therapy (462)
Cervical cancer (21)
Clinical research (68133)
Collaboration (899)
Company closure (2)
Compensation (567)
Complete response letters (23)
COVID-19 (2737)
CRISPR (44)
C-suite (256)
Cystic fibrosis (103)
Data (2334)
Decentralized trials (2)
Denatured (35)
Depression (49)
Diabetes (281)
Diagnostics (6592)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (129)
Drug pricing (118)
Drug shortages (28)
Duchenne muscular dystrophy (100)
Earnings (90812)
Editorial (46)
Employer branding (23)
Employer resources (153)
Events (119141)
Executive appointments (764)
FDA (18231)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (794)
Gene editing (116)
Generative AI (26)
Gene therapy (335)
GLP-1 (774)
Government (4738)
Grass and pollen (6)
Guidances (150)
Healthcare (19688)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (134)
Indications (30)
Infectious disease (2885)
Inflammatory bowel disease (151)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (99)
Interviews (434)
IPO (16788)
IRA (47)
Job creations (4047)
Job search strategy (1779)
Kidney cancer (10)
Labor market (43)
Layoffs (504)
Leadership (21)
Legal (8602)
Liver cancer (77)
Lung cancer (332)
Lymphoma (158)
Machine learning (9)
Management (61)
Manufacturing (341)
MASH (78)
Medical device (13796)
Medtech (13801)
Mergers & acquisitions (20267)
Metabolic disorders (740)
Multiple sclerosis (86)
NASH (18)
Neurodegenerative disease (101)
Neuropsychiatric disorders (30)
Neuroscience (2001)
NextGen: Class of 2025 (6921)
Non-profit (4805)
Now hiring (40)
Obesity (393)
Opinion (245)
Ovarian cancer (81)
Pain (95)
Pancreatic cancer (90)
Parkinson's disease (154)
Partnered (22)
Patents (248)
Patient recruitment (117)
Peanut (50)
People (60256)
Pharmaceutical (65)
Pharmacy benefit managers (22)
Phase I (21144)
Phase II (29865)
Phase III (22438)
Pipeline (1368)
Policy (167)
Postmarket research (2824)
Preclinical (9171)
Press Release (67)
Prostate cancer (114)
Psychedelics (33)
Radiopharmaceuticals (257)
Rare diseases (405)
Real estate (6294)
Recruiting (67)
Regulatory (23455)
Reports (48)
Research institute (2445)
Resumes & cover letters (412)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (74)
Series A (137)
Series B (90)
Service/supplier (12)
Sickle cell disease (56)
Special edition (19)
Spinal muscular atrophy (151)
Sponsored (30)
Startups (3771)
State (2)
Stomach cancer (15)
Supply chain (73)
Tariffs (52)
The Weekly (63)
Vaccines (750)
Venture capitalists (44)
Weight loss (261)
Women's health (38)
Worklife (17)
Date
Today (162)
Last 7 days (950)
Last 30 days (3164)
Last 365 days (33363)
2025 (12065)
2024 (36143)
2023 (40975)
2022 (52259)
2021 (56969)
2020 (55647)
2019 (48619)
2018 (36732)
2017 (33802)
2016 (33721)
2015 (39693)
2014 (33858)
2013 (29338)
2012 (31253)
2011 (31654)
2010 (30086)
Location
Africa (881)
Alabama (57)
Alaska (7)
Arizona (238)
Arkansas (14)
Asia (41256)
Australia (6845)
California (6460)
Canada (2078)
China (554)
Colorado (281)
Connecticut (296)
Delaware (158)
Europe (91104)
Florida (956)
Georgia (216)
Idaho (58)
Illinois (574)
India (26)
Indiana (325)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (25)
Louisiana (11)
Maine (64)
Maryland (943)
Massachusetts (4850)
Michigan (234)
Minnesota (402)
Mississippi (2)
Missouri (85)
Montana (27)
Nebraska (26)
Nevada (67)
New Hampshire (67)
New Jersey (1830)
New Mexico (30)
New York (1821)
North Carolina (1048)
North Dakota (8)
Northern California (2833)
Ohio (215)
Oklahoma (15)
Oregon (35)
Pennsylvania (1432)
Puerto Rico (13)
Rhode Island (34)
South America (1268)
South Carolina (25)
South Dakota (1)
Southern California (2432)
Tennessee (107)
Texas (953)
United States (24384)
Utah (189)
Virginia (158)
Washington D.C. (67)
Washington State (565)
West Virginia (3)
Wisconsin (57)
741,368 Results for "john wiley and sons inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Wiley Announces Collaboration With Amazon Web Services (AWS) to Integrate Scientific Content Into Life Sciences AI Agents
May 5, 2025
·
4 min read
Press Releases
MindMed Appoints Matt Wiley as Chief Commercial Officer
March 17, 2025
·
7 min read
Press Releases
Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University
March 7, 2025
·
4 min read
Press Releases
Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors
March 5, 2025
·
4 min read
Press Releases
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
April 29, 2025
·
3 min read
Press Releases
Wiley Announces Quarterly Dividend
December 12, 2024
·
1 min read
Press Releases
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
April 17, 2025
·
2 min read
Drug Development
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that the safety of SON-1010 dosing has been formally reviewed in both of the current Phase 1 clinical trials and the Company is now increasing the target dose of SON-1010 during dose escalation.
May 20, 2024
·
11 min read
Press Releases
Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial
April 29, 2025
·
12 min read
Business
Wiley Hosts Investor Update
Wiley (NYSE: WLY and WLYB), one of the world’s largest publishers and a global leader in research and learning, will host its Investor Update today at 10 am E.T. to discuss the company’s business and financial outlook.
January 25, 2024
·
5 min read
1 of 74,137
Next
